thymidine labelling index
Recently Published Documents


TOTAL DOCUMENTS

28
(FIVE YEARS 0)

H-INDEX

12
(FIVE YEARS 0)

1998 ◽  
Vol 34 ◽  
pp. S21
Author(s):  
P. Pronzato ◽  
M.R. Sertoli ◽  
M. Venturini ◽  
L. Del Mastro ◽  
P. Queirolo ◽  
...  

1997 ◽  
Vol 30 (3) ◽  
pp. 117-126 ◽  
Author(s):  
A. Becciolini ◽  
M. Balzi ◽  
M. Barbarisi ◽  
P. Faraoni ◽  
A. Biggeri ◽  
...  

1997 ◽  
Vol 30 (3-4) ◽  
pp. 117-126 ◽  
Author(s):  
A. Becciolini ◽  
M. Balzi ◽  
M. Barbarisi ◽  
P. Faraoni ◽  
A. Biggeri ◽  
...  

1995 ◽  
Vol 10 (2) ◽  
pp. 122-123
Author(s):  
G.M.R. Saccani Jotti ◽  
M. Gabrielli ◽  
N. Orsi ◽  
M. Fontanesi ◽  
G. Sansebastiano ◽  
...  

1994 ◽  
Vol 9 (2) ◽  
pp. 109-114 ◽  
Author(s):  
M. Gion ◽  
R. Mione ◽  
A. Becciolini ◽  
M. Balzi ◽  
M. Correale ◽  
...  

The serological tumor marker tissue polypeptide antigen (TPA) and the more recently identified tissue-specific polypeptide antigen (TPS) have been reported to be indicators of the proliferation rate of the tumor. In the present investigation we compared the cytosol level of the two markers with the proliferative activity of the tumor measured using the 3H-thymidine labelling index. The preliminary results presented here show that higher TLI is associated with lower cytosol levels of both TPA and TPS. TPA and TPS in the cytosol were significantly associated. These findings are in agreement with the previously demonstrated association between high TPA cytosol levels and better prognosis in breast cancer. Further studies are ongoing in order to: 1. confirm these findings in a larger patient series; 2. investigate any possible prognostic indication provided by TPS; 3. evaluate any possible biological meaning of the negative association between TPA/ TPS and TLI in the cytosol of breast cancer.


Sign in / Sign up

Export Citation Format

Share Document